Newly Diagnosed T1D

Newly Diagnosed T1D

Many people newly diagnosed are making some insulin. You may have heard this referred to as the “honeymoon phase.” The goal of our studies is to maintain insulin production for as long as possible. Research shows that maintaining insulin production results in fewer complications, better glucose control, and lower A1C levels. Our studies for people newly diagnosed with T1D (Stage 3) are testing ways to preserve insulin and slow down or stop disease progression. These studies usually require participants join within 100 days of diagnosis. 

Current Newly Diagnosed Studies

Although TrialNet currently does not have studies for people newly diagnosed, the Immune Tolerance Network is enrolling participants into the EXTEND study. Please visit www.extendstudy.org for more information.